Abstract

In general, screenings include an identification of disease or disease precursors among presumptively healthy individuals. There are two different main approaches to cancer screening: prevention of disease by finding and removing premalignant precursors of cancer; and early detection of cancer where the goal is to treat the invasive cancer in an early curable stage.

Screening for cancer is implemented in many countries. Some screening tests are evaluated in randomized trials before implementation, whereas others have been introduced without randomized trials. Even for screening tests previously shown to be effective in randomized trials, there is concern that today, they may not be as effective as shown in the trials.

This talk will address how we can give our population the best cancer screening options.

Professor Mette Kalager is Professor at the Department of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine at the University of Oslo, Norway.

This seminar will be chaired by Dr Mark Kroese, Consultant in Public Health Medicine and Director of the PHG Foundation.